SignatureFD’s ChemoCentryx, Inc. CCXI Stock Holding History

SignatureFD’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-72	Closed	-$4K	–	3461
2022 Q3	$4K	Buy	72 +1	+1%	+$41	﹤0.01%	2590
2022 Q2	$2K	Sell	71 -28	-28%	-$617	﹤0.01%	2851
2022 Q1	$2K	Sell	99 -17	-15%	-$478	﹤0.01%	2910
2021 Q4	$4K	Buy	116 +45	+63%	+$1.58K	﹤0.01%	2534
2021 Q3	$1K	Buy	71 +32	+82%	+$499	﹤0.01%	2989
2021 Q2	$1K	Hold	39	–	–	﹤0.01%	2907
2021 Q1	$2K	Hold	39	–	–	﹤0.01%	2564
2020 Q4	$2K	Hold	39	–	–	﹤0.01%	2349
2020 Q3	$2K	Sell	39 -27	-41%	-$1.45K	﹤0.01%	2324
2020 Q2	$4K	Buy	66 +27	+69%	+$1.47K	﹤0.01%	1927
2020 Q1	$2K	Buy	+39	New	+$1.66K	﹤0.01%	2032

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SignatureFD's CCXI Position: Q4 2022 in Review

SignatureFD sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 72 shares — an estimated $4K sold.

SignatureFD first reported a position in CCXI in Q1 2020 and held it in 11 quarters. The position peaked at $4K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

SignatureFD reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
SignatureFD sold 72 ChemoCentryx, Inc. shares in Q4 2022, an estimated $4K.
SignatureFD first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 11 quarters.
SignatureFD's ChemoCentryx, Inc. position peaked at $4K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.